510(k) Report

510(k) · Cleared

Cleared

Atlantik

K070794510(k) AbbreviatedCleared Jul 10, 2007110-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medical Biomat · MQV Filler, Bone Void, Calcium Compound

Cleared on Jul 10, 2007 as substantially equivalent to K051774 (Biomatlante, 2006) and 1 other predicate after a 110-day review. Its family tree reaches back 5 generations to 1999.

Decided
Jul 10, 2007
Review
110 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
2

Its longest line of descent runs back 5 generations to K990131 (1999). 10 ancestors in all, the oldest K960978 (1996). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2003: 1 other ancestor2000: 1 other ancestor1998: 1 other ancestor1997: 1 other ancestor1996: 1 other ancestorK990131 · Pro Osteon Implant 500R Resorbable Bone Graft Substitute · Interpore Cross Intl. · 1999K020986 · Mastergraft Resorbable Ceramic · Medtronic Sofamor Danek, Inc. · 2002K032268 · MBCP · Biomatlante · 2003K043005 · Modification to MBCP · Biomatlante · 2005K051774 · MBCP · Biomatlante · 20061996199820002002200420062008
  1. Root · 5 generations backK990131 Pro Osteon Implant 500R Resorbable Bone Graft SubstituteInterpore Cross Intl. · 1999
  2. 4 generations backK020986 Mastergraft Resorbable CeramicMedtronic Sofamor Danek, Inc. · 2002
  3. 3 generations backK032268 MBCPBiomatlante · 2003
  4. 2 generations backK043005 Modification to MBCPBiomatlante · 2005
  5. 1 generation backK051774 MBCPBiomatlante · 2006
  6. This deviceK070794 AtlantikMedical Biomat · 2007
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K990131Pro Osteon Implant 500R Resorbable Bone Graft SubstituteInterpore Cross Intl.1999—
−4K020986Mastergraft Resorbable CeramicMedtronic Sofamor Danek, Inc.2002—
−3K032268MBCPBiomatlante2003—
−2K043005Modification to MBCPBiomatlante2005—
−1K051774MBCPBiomatlante2006—
0 (this device)K070794AtlantikMedical Biomat2007—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
199710
199810
200010
200310
FIG. 1 — Lineage of K070794, 1999–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K051774MBCPBiomatlante2006—
*K030131Ossatura BCP Bone Void Filler
Summary page 1
…E DEVICES: Biomatlante MBCP TM Bone Void Filler (KO51774) IsoTis NV OsSaturaTM BCP Bone Void Filler (K030131) DEVICES DESCRIPTION: ATLANTIK TM is a synthetic and osteoconductive bone void filler. It is a microporous and macro…
Isotis NV2003—

Also cleared against K051774: 9 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 8 years and passes through 4 companies; a new generation was cleared every 1.4 years on median.
  • None of the 10 ancestors has a recall.
  • 9 other devices also cite its predicate K051774.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

ATLANTIKTM is intended for use as a bone void filler for bony voids or gaps of the skeletal system (e.g. extremities and pelvis) that are not intrinsic to the stability of the bony structure. These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone.

ATLANTIKTM is a bone void filler without initial mechanical properties. Therefore rigid fixation techniques may often be recommended.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K070794: Atlantik.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K070794

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026